日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma.

新型 PROTAC 靶向 FKBP12:增强骨形态发生蛋白活性和多发性骨髓瘤细胞凋亡的潜力。

Quist-Lokken Ingrid, Tilseth Mira, Andersson-Rusch Clara, Hanif Md Abu, Walz Michael, Moen Johanna Fredrikke Nordstrand, Vik Megan Anne, Slordahl Tobias Schmidt, Sundan Anders, Hausch Felix, Holien Toril

Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone

羟氯喹、卡非佐米和地塞米松联合抑制蛋白酶体和自噬治疗复发/难治性多发性骨髓瘤的I期临床试验

Slørdahl, Tobias S; Askeland, Frida Bugge; Hanssen, Margrete Sofie Sætre; Hov, Håkon; Sundt-Hansen, Stine Marie; Lindahl, Sofia; Vethe, Nils Tore; Hjorth-Hansen, Henrik; Fenstad, Mona H; Waage, Anders; Hjertner, Øyvind; Schjesvold, Fredrik; Sundan, Anders

Receptor binding competition: A paradigm for regulating TGF-β family action

受体结合竞争:调控TGF-β家族作用的范例

Martinez-Hackert, Erik; Sundan, Anders; Holien, Toril

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

旁观者记忆T细胞与IMiD/检查点疗法在多发性骨髓瘤中的应用:一场危险的探戈?

Sponaas, Anne Marit; Waage, Anders; Vandsemb, Esten N; Misund, Kristine; Børset, Magne; Sundan, Anders; Slørdahl, Tobias Schmidt; Standal, Therese

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade

在多发性骨髓瘤中,CD39和CD73介导的ATP转化为腺苷的过程可以与腺苷受体A2A阻断剂联合使用,从而达到治疗目的。

Yang, Rui; Elsaadi, Samah; Misund, Kristine; Abdollahi, Pegah; Vandsemb, Esten Nymoen; Moen, Siv Helen; Kusnierczyk, Anna; Slupphaug, Geir; Standal, Therese; Waage, Anders; Slørdahl, Tobias S; Rø, Torstein Baade; Rustad, Even; Sundan, Anders; Hay, Carl; Cooper, Zachary; Schuller, Alwin G; Woessner, Richard; Borodovsky, Alexandra; Menu, Eline; Børset, Magne; Sponaas, Anne Marit

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy

更正:骨髓瘤细胞系中MYC扩增:与MYC抑制剂疗效的相关性

Holien, Toril; Misund, Kristine; Olsen, Oddrun Elise; Baranowska, Katarzyna Anna; Buene, Glenn; Børset, Magne; Waage, Anders; Sundan, Anders

Monitoring multiple myeloma by quantification of recurrent mutations in serum

通过定量检测血清中复发性突变来监测多发性骨髓瘤

Rustad, Even Holth; Coward, Eivind; Skytøen, Emilie R; Misund, Kristine; Holien, Toril; Standal, Therese; Børset, Magne; Beisvag, Vidar; Myklebost, Ola; Meza-Zepeda, Leonardo A; Dai, Hong Yan; Sundan, Anders; Waage, Anders

Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss

缺氧促进骨髓瘤细胞中 IL-32 的表达,高表达与生存率低和骨质流失有关

Muhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, Siv Helen Moen, Kristine Misund, Katarzyna Maria Psonka-Antonczyk, Mariaserena Giliberto, Glenn Buene, Anders Sundan, Anders Waage, Anne-Marit Sponaas, Therese Standal

Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease

生长分化因子15 (GDF15) 促进破骨细胞分化并抑制成骨细胞分化,血清GDF15水平升高与多发性骨髓瘤骨病相关。

Westhrin, Marita; Moen, Siv Helen; Holien, Toril; Mylin, Anne Kærsgaard; Heickendorff, Lene; Olsen, Oddrun Elise; Sundan, Anders; Turesson, Ingemar; Gimsing, Peter; Waage, Anders; Standal, Therese

Allelic mutations in noncoding genomic sequences construct novel transcription factor binding sites that promote gene overexpression.

非编码基因组序列中的等位基因突变构建了新的转录因子结合位点,从而促进基因过度表达

Tian Erming, Børset Magne, Sawyer Jeffrey R, Brede Gaute, Våtsveen Thea K, Hov Håkon, Waage Anders, Barlogie Bart, Shaughnessy John D Jr, Epstein Joshua, Sundan Anders